• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Late-life mentally stimulating activities may decrease risk of mild cognitive impairment

byShayna BejaimalandAnees Daud
February 1, 2017
in Chronic Disease, Neurology, Psychiatry
Reading Time: 3 mins read
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Share on FacebookShare on TwitterShare on LinkedIn

1. This prospective cohort study showed that mentally stimulating activities (computer use, craft activities, social activities and playing games) in late-age (>70 years old) were associated with decreased risk of incident mild cognitive impairment (MCI).

2. When stratified by apolipoprotein E ε4 (APOE ε4) carrier status, those at lowest risk of developing MCI engaged in mentally stimulating activities and were non-carriers of APOE ε4, and those at highest risk did not partake in mentally stimulating activities and were APOE ε4 carriers.

Evidence Rating Level: 2 (Good)

Study Rundown: Dementia is a common morbid condition among the elderly. Given lack of current medical treatment, prevention through lifestyle modification is important to investigate. Previous studies have shown an association between mentally stimulating activities and mild cognitive impairment (MCI), however it is unclear how these activities, if done in later life, can impact incidence of MCI. This population-based prospective cohort study aimed to investigate the effect of late-life mentally stimulating activities on the incidence of MCI and to evaluate the influence of the apolipoprotein E ε4 (APOE ε4) genotype.

Certain late-life mentally stimulating activities, such as playing games, engaging in craft activities, computer use, and social activities, significantly decreased the risk of MCI. When stratified for APOE ε4 genotype, lowest risk of MCI was among participants without APOE ε4 and who engaged in mentally stimulating activities. The highest risk was among participants who were APOE ε4 carriers and who did not engage in these activities. Strengths of this study included its population-based cohort and robust outcome analysis using many validated neurocognitive-testing tools. Limitations included use of questionnaires to determine the exposure of interest, thus affected by recall bias. Also, effects of activities conducted earlier in life may also have confounded the results.

Click to read the study, published today in JAMA Neurology

RELATED REPORTS

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

2 Minute Medicine Rewind October 12, 2026

Relevant Reading: Risk and protective factors for cognitive impairment in persons aged 85 years and older

In-Depth [prospective cohort]: This prospective, population-based cohort study was conducted from April 2006 to June 2016 using patients from the Mayo Clinic Study of Aging (MCSA) in Olmsted County, Minnesota. This cohort included participants 70 or older who were cognitively normal at baseline. Information about the frequency of mentally stimulating activities (reading books, craft activities, computer use, playing games, social activities) was gathered for the year prior to enrollment into the MCSA as the exposure of interest. Additionally, blood samples were taken to determine the participants APOE ε4 genotype. These participants were then followed for 4 years for the primary outcome of incident MCI diagnosed as per published criteria. Statistical analysis included hazard ratio calculations with Cox proportional hazards regression models.

This study of 1,929 participants showed that certain late-life mentally stimulating activities significantly decreased the risk of MCI. These activities included: playing games (HR 0.78; 95% CI 0.65-0.95), engaging in craft activities (HR 0,72; 95% CI 0.57-0.90), computer use (HR 0.70; 95% CI 0.57-0.85) and social activities (HR 0.77; 95% CI 0.58-0.92). When stratified for APOE ε4 genotype, those with lowest risk of MCI were APOE ε4 non-carriers who engaged in mentally stimulating activities and those at highest risk were APOE ε4 carriers who did not engage in mentally stimulating activities.

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alzheimercognitive declinedementia
Previous Post

Lessons from real-world implementation of lung cancer screening

Next Post

2 Minute Medicine Rewind January 30, 2017

RelatedReports

A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 17, 2026
An illustration showing a brain scan alongside a human brain, symbolizing brain health and cognitive decline.
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

Dementia diagnosis underreporting is common and associated with reduced care engagement

August 29, 2026
Next Post
Intrapartum serum prolactin may predict risk of postpartum diabetes

2 Minute Medicine Rewind January 30, 2017

Crizanlizumab use lowers rates of sickle cell crises

Crizanlizumab use lowers rates of sickle cell crises

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Adding antiandrogen therapy to radiation improves overall survival in recurrent prostate cancer

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants
  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.